In the present study, we were interested to analyze the effects of HSF1 activation (Hsp90 inhibitor NVP-AUY922) and inhibition (NZ28, HSF1 knockdown) in different human cancer cells on the NK cell ligands MICA/B and its consequences on NK cell-mediated lysis. This evidence concerns the gene HSF1 and cancer.